TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma

• Main Authors: Rebbani, K, Marchio, A, Ezzikouri, S, Afifi, R, Kandil, M, Bahri, O, Triki, H, Essaid El Feydi, A, Dejean, A, Benjelloun, S, Pineau, P
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: 2020
• Subjects: 5 aza 2' deoxycytidine; clu protein; doxorubicin; glutathione transferase P1; microRNA; microRNA 203; microRNA 663; nrg1 protein; protein p53; Ras association domain family protein 1A; riz1 protein; suppressor of cytokine signaling 1; telomerase reverse transcriptase; tumor necrosis factor related apoptosis inducing ligand receptor 3; unclassified drug; codon; adult; Article; cell viability; chromosomal instability; chromosome 17p; clinical article; controlled study; DNA methylation; female; gene inactivation; gene locus; genetic variability; genotype; heterozygosity loss; human; human cell; human tissue; in vitro study; liver cancer cell line; liver cell carcinoma; male; MTT assay; peripheral blood mononuclear cell; polymerase chain reaction; protein expression; protein polymorphism; single nucleotide polymorphism; somatic mutation; Western blotting; Africa; aged; cell line; genetics; liver tumor; middle aged; Adult; Africa, Northern; Aged; Carcinoma, Hepatocellular; Cell Line; Codon; DNA Methylation; Female; Genotype; Humans; Liver Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181453
• Institution: National University of Singapore

10.1186/s12943-015-0340-2